Address & contact
https://www.ncc.go.jp/Specialties
Reports that name this provider
- Clinical Trial Access in Japan
- Conducts 507 registration-directed trials and 230 investigator-initiated trials as of April 2022. JCOG (Japan Clinical Oncology Group) headquartered here. Maintains 7 authorized medical coordinating agents offering multilingual services. BELIEVE Trial (NCCH1901) provides off-label investigational drug access; 20 off-label drugs available as of September 2022. Recognized in Newsweek World's Best Specialized Hospitals 2021.
- End-of-Life Counseling in Japan
- Department of Psycho-Oncology established 1999; Department of Palliative Medicine offers integrated services with multidisciplinary team including palliative care specialists, psycho-oncologists, certified nurses, pharmacists, psychologists, acupuncturists; has international patient desk; requires all non-Japanese speakers to work through designated coordinating agents
- Genetic Testing Availability in Japan
- Established Japan's first hereditary cancer genetic counseling clinic in 1998; explicitly accepts international patients with basic English-language support; operates C-CAT national cancer genomics database
- Oncologic Surgery Quality in Japan
- Newsweek World's Best Specialized Hospitals 2024 and 2025 (Oncology); Special Functioning Hospital; Designated Core Hospital for Cancer Genomic Medicine; National Institute for Rare Cancers; National Institute for Childhood Cancers; Clinical Research Core Hospital; ESMO-accredited; CAP laboratory accreditation; ISO 9001:2015 and ISO 15189; employs full-time cancer specialists for all organ systems; Japan International Hospitals (JIH) designation; Department of International Medical and Advanced Care for overseas patients
- Radiation Therapy Quality in Japan
- Established 1962; second hospital-based proton beam therapy system in the world (operational from April 1997); operates dedicated Section of Radiation Safety and Quality Assurance
- Specialized Diagnostics in Japan
- WEO Center of Excellence; Endoscopy Center; accepts international patients through coordinating agents in English, Chinese, Korean, Vietnamese, Russian, and Spanish; ¥132,000 for second opinions, ¥148,500–¥181,500 for pathological consultations
- Stem Cell Therapy Availability in Japan
- Department of Hematopoietic Stem Cell Transplantation for cancer patients
- Stem Cell Transplant Quality in Japan
- Has a dedicated Department of Hematopoietic Stem Cell Transplantation; nationally prominent academic center